Laryngopharyngeal reflux disease in the Greek general population, prevalence and risk factors
Tóm tắt
To assess the prevalence of laryngopharyngeal reflux (LPR) in the Greek general population and its risk factors. Questionnaire based epidemiological, adult participants’ survey. The Reflux Symptom Index (RSI) was used for the assessment of LPR prevalence. The RSI questionnaire was completed by 340 (183 male and 157 female) randomly selected subjects. Subjects with RSI score ≥13 were considered as LPR patients and those with RSI score <13 were considered as non LPR subjects. The prevalence of LPR in the general Greek population was found to be 18.8 % with no statistically significant difference between the two genders (p > 0.05). The age group of 50–64 years showed the higher prevalence rate. Tobacco smoking and alcohol consumption were found to be related with LPR. No reported concomitant disease or medication was found to be related with LPR. LPR prevalence in the Greek general population was found to be 18.8 %. Tobacco smoking and alcohol consumption were found to be related with LPR.
Tài liệu tham khảo
Koufman JA, Aviv JE, Casiano RR, Shaw YG. Laryngopharyngeal reflux: position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg. 2002;127:32–5.
Cheung TK, Lam PK, Wei WI, Wong WM, Ng ML, Gu Q, et al. Quality of life in patients with laryngopharyngeal reflux. Digestion. 2009;79:52–7.
Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002;16:274–7.
Lin CC, Wang YY, Wang KL, Lien HC, Liang MT, Yen TT, et al. Association of heartburn and laryngopharyngeal symptoms with endoscopic reflux esophagitis, smoking, and drinking. Otolaryngol Head Neck Surg. 2009;141(2):264–71.
Sanghoon P, Hoon JC, Bora K, Chang-Sub U, Seung-Kuk B, Kwang-Yoon J, et al. An electron microscopic study—Correlation of gastroesophageal reflux disease and laryngopharyngeal reflux. Laryngoscope. 2010;120:1303–8.
Habermann W, Schmid C, Neumann K, DeVaney T, Hammer H. Reflux symptom index and reflux finding score in otolaryngologic practice. J Voice. 2012;26(3):e123–7.
Feng GJ, Zhang LH, Zhao LL, Liu YL. A pilot study on diagnosing laryngopharyngeal reflux disease by pH monitoring in laryngopharynx. Zhonghua Yi Xue Za Zhi. 2008;88(12):805–8.
Gupta R, Sataloff RT. Laryngopharyngeal reflux: current concepts and questions. Curr Opin Otolaryngol Head Neck Surg. 2009;17(3):143–8.
Reulbach TR, Belafsky PC, Blalock PD, Koufman JA, Postma GN. Occult laryngeal pathology in a community-based cohort. Otolaryngol Head Neck Surg. 2001;124:448–50.
Kοufman JA. The Otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24 h pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope. 1991;101 Suppl 52:1–78.
Hopkins C, Yousaf U, Pedersen M. Acid reflux treatment for hoarseness. The Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005054. doi:10.1002/14651858.CD005054.pub2.
Vincent DA, Garrett JD, Radionoff SL, Reussner LA, Stasney CR. The proximal probe in esophageal pH monitoring: development of a normative database. J Voice. 2000;14(2):247–54.
Ozturk O, Oz F, Karakullukcu B, Oghan F, Guclu E, Ada M. Hoarseness and laryngopharyngeal reflux: a cause and effect relationship or coincidence? Eur Arch Otorhinolaryngol. 2006;263:935–9.
Sone M, Katayama N, Kato T, Izawa K, Wada M, Hamajima N, et al. Prevalence of laryngopharyngeal reflux symptoms: comparison between health checkup examinees and patients with otitis media. Otolaryng Head Neck Surg. 2012;146:562–6.
Reavis KM, Morris CD, Gopal DV, Hunter JG, Jobe BA. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms. Ann Surg. 2004;239:849–56.
Galli J, Cammarota G, Volante M, De Corso E, Almadori G, Paludetti G. Laryngeal carcinoma and laryngo-pharyngeal reflux disease. Acta Otorhinolaryng Ital. 2006;26:260–3.
Lowden M, McGlashan JA, Steel A, Strugala V, Dettmar P. Prevalence of symptoms suggestive of extra-oesophageal reflux in a general practice population in UK. Logoped Phoniatr Vocol. 2009;34:32–5.
Kamani T, Penney S, Midra I, Pothula V. The prevalence of laryngopharyngeal reflux in the English population. Eur Arch Otorhinolaryngol. 2012. doi:10.1007/S00405-012-2028-1.
Printza A, Kyrgidis A, Oikonomidou E, Triaridis S. Assessing laryngopharyngeal reflux symptoms with the reflux symptom index: validation and prevalence in the Greek population. Otolaryngol Head Neck Surg. 2011;145:974–80.
Gasiorowska A, Poh CH, Fass R. Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders? Dig Dis Sci. 2009;54(9):1829–34.
Ruigomez A, Rodriguez LA, Wallander MA, Johansson S, Graffner H, Dent J. Natural history of gastro-oesophageal reflux in a general practice population in the UK. Aliment Pharmacol Ther. 2004;20:751–60.
Lai YC, Wang PC, Lin JC. Laryngopharyngeal reflux in patients with reflux esophagitis. World J Gastoenterol. 2008;14(28):4523–8.
Saruç M, Aksoy EA, Vardereli E, Karaaslan M, Çiçek B, İnce Ü, et al. Risk factors for laryngopharyngeal reflux. Eur Arch Otorhinolaryngol. 2012;269:1189–94.
Thompson WG, Heaton KW. Heart burn and globus in apparently healthy people. Can Med Assoc J. 1982;126:46–8.
Martinucci I, de Bortoli N, Savarino E, Nacci A, Romeo SO, Bellini M, et al. Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis. 2013;4:287–301.